Rapamycin treatment correlates changes in primary cilia expression with cell cycle regulation in epithelial cells

Biochem Pharmacol. 2020 Aug:178:114056. doi: 10.1016/j.bcp.2020.114056. Epub 2020 May 26.

Abstract

Primary cilia are sensory organelles that regulate cell cycle and signaling pathways. In addition to its association with cancer, dysfunction of primary cilia is responsible for the pathogenesis of polycystic kidney disease (PKD) and other ciliopathies. Because the association between cilia formation or length and cell cycle or division is poorly understood, we here evaluated their correlation in this study. Using Spectral Karyotyping (SKY) technique, we showed that PKD and the cancer/tumorigenic epithelial cells PC3, DU145, and NL20-TA were associated with abnormal ploidy. We also showed that PKD and the cancer epithelia were highly proliferative. Importantly, the cancer epithelial cells had a reduction in the presence and/or length of primary cilia relative to the normal kidney (NK) cells. We then used rapamycin to restore the expression and length of primary cilia in these cells. Our subsequent analyses indicated that both the presence and length of primary cilia were inversely correlated with cell proliferation. Collectively, our data suggest that restoring the presence and/or length of primary cilia may serve as a novel approach to inhibit cancer cell proliferation.

Keywords: Cancer; Karyotyping; Polycystic kidney disease; Proliferation; Wnt signalling.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibiotics, Antineoplastic / pharmacology*
  • Antibiotics, Antineoplastic / therapeutic use
  • Cell Cycle Checkpoints / drug effects*
  • Cell Cycle Checkpoints / physiology
  • Cell Line, Tumor
  • Cell Proliferation / drug effects*
  • Cell Proliferation / physiology
  • Cilia / drug effects*
  • Cilia / metabolism
  • Cilia / pathology
  • Epithelial Cells / drug effects*
  • Epithelial Cells / metabolism
  • Epithelial Cells / pathology
  • Humans
  • Polycystic Kidney Diseases / drug therapy
  • Polycystic Kidney Diseases / metabolism
  • Polycystic Kidney Diseases / pathology
  • Sirolimus / pharmacology*
  • Sirolimus / therapeutic use

Substances

  • Antibiotics, Antineoplastic
  • Sirolimus